You are here

Zepbound

Regeneron, Lilly grapple with clinical endpoints as obesity space moves to improving weight loss

Fierce Biotech

Thu, 05/2/24 - 10:14 pm

How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo Nordisk

Yahoo Finance

Tue, 04/30/24 - 08:56 am

Why the obesity drug market is about to get a lot more crowded

Medical Marketing and Media

Fri, 04/26/24 - 11:49 am

Meet Eli Lilly's Secret Weapon in the Billion-Dollar Weight-Loss Drug Market

Motley Fool

Wed, 04/24/24 - 08:43 am

Lilly to buy injectable drug plant in manufacturing ramp-up

BioPharma Dive

Mon, 04/22/24 - 05:54 pm

drug manufacturing

Drugs Like Ozempic And Mounjaro Could Treat Other Conditions—Here’s What Scientists Are Looking At

Forbes

Thu, 04/18/24 - 10:25 pm

Lilly eyes Zepbound label expansion after clearing phase III sleep apnea study

BioSpace

Wed, 04/17/24 - 11:32 am

Most of Lilly's Mounjaro and Zepbound doses in limited supply, FDA says

Reuters

Wed, 04/17/24 - 11:21 am

Could Viking Therapeutics Become the Next Eli Lilly?

Motley Fool

Fri, 03/22/24 - 09:27 am

Viking Therapeutics

GLP-1s set to take drug sales throne from PD-1 inhibitors in 2024

Medical Marketing and Media

Wed, 03/20/24 - 09:43 pm

PD-1 inhibitors

Eli Lilly strikes deal with Amazon: Will the ecommerce giant become go-to destination for GLP-1s?

Biopharma Reporter

Mon, 03/18/24 - 11:02 am

Lilly weight-loss drug Zepbound new US prescriptions surpass Wegovy for first time

Reuters

Sun, 03/17/24 - 09:17 pm

Lilly makes weight-loss drug Zepbound available through Amazon pharmacy

BioSpace

Wed, 03/13/24 - 11:18 am

Amazon pharmacy

Americans don't think weight-loss drugs will fix the obesity epidemic

Axios

Wed, 02/28/24 - 10:44 am

GLP1ra’s beyond obesity and diabetes: Is the sky the limit?

Clinical Trials Arena

Mon, 02/26/24 - 11:03 am

Lilly expects strong 2024 profit on rising weight-loss drug demand

Reuters

Tue, 02/6/24 - 10:16 am

Eli Lilly mounts clinical and commercial case for tirzepatide as Mounjaro, Zepbound chalk up major gains

Fierce Pharma

Tue, 02/6/24 - 09:33 am

United States of Ozempic: Where anti-obesity drugs are taking off

Axios

Fri, 01/19/24 - 09:31 am

Zepbound shortage could be around the corner

Beckers Hospital Review

Tue, 01/9/24 - 10:05 pm

Novo Nordisk, Eli Lilly's weight-loss drugs under FDA scrutiny for suicidal thoughts, hair loss

Fierce Pharma

Thu, 01/4/24 - 11:53 am

Pages